Also, positive results in maintaining blood sugar control, blood pressure and cholesterol levels have significantly demonstrated potential therapeutic applications
Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal survival, and the progression of neurodegenerative disorders
PMCID: PMC9917998
Other diabetes medications: insulin, dulaglutide, exenatide, liraglutide, Byetta, Trulicity, Victoza, and similar drugs
Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare